Ebola prevention drug trial enrolls 250-plus in Congo

· Science · DR Congo

More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo. Experts describe it as a critical step in fighting the deadliest outbreak of the disease in the Central African country.

Why it matters：Preventive drugs, rather than treatments alone, could change how outbreaks are contained in regions where Ebola recurs, and this trial is a large test of that approach.

Key points

  • More than 250 participants have been enrolled.
  • The drug is intended to prevent Ebola infection, not treat it.
  • It is aimed at the deadliest outbreak recorded in Congo.

Sources (original reporting)

More stories from this day